However, the fact that the HER-2 positive samples, which are considered to present a worse prognosis than the ER/PR positive and triple positive tumors, presented the second highest HK and PFK activity strengthens the correlation between the enzyme activity and the prognosis for breast cancer patients. The gene discussed is ESR1; the disease is breast carcinoma.